Proprietary Product Portfolio

Hovione’s product portfolio consists of innovative, proprietary drug products in the areas of Dermatology, Ophthalmology, and Respiratory.

Hovione’s product portfolio is comprised of known Active Pharmaceutical Ingredients (APIs) which have been formulated to meet patient needs by increasing safety, improving compliance or expanding access by following the FDA 505(b)2 regulatory pathway. We focus on the fields of dermatology, ophthalmology and respiratory and target new routes of administration, expansion of indications and improved delivery. Hovione develops its products through Phase 1/2 and seeks partners for completion of the clinical development, regulatory approval, and commercialization.

Product List

DERMATOLOGY
Product Condition Dosage Form Formulation
Development
Non-Clinical Clinical Phase Partnering Clinical Trial
HY01 Rosacea Topical Gel Completed Completed Phase 2b completed Available Clinical Design
OPHTHALMOLOGY
Product Condition Dosage Form Formulation
Development
Non-Clinical Clinical Phase Partnering Clinical Trial
HY02 Blepharitis
Dry eye disease
Sterile ointment Completed On-going Phase 2b
on-going
Available Clinical Design

RESPIRATORY
Product Condition Dosage Form Formulation
Development
Non-Clinical Clinical Phase 1/2 Partnering
IH11 Asthma TwinCaps® DPI On-going Available

To learn more about our projects please contact our team.

Related Files

Also in Proprietary Product Licensing